BiomX Inc.
PHGE-WT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.00 Million |
|---|---|
| Enterprise Value | $8.02 Million |
| Earnings per Share | $- |
| Beta | 0 |
| Outstanding Shares | - |
Return
| Return on Equity | 684.26% |
|---|---|
| Return on Assets | 263.77% |
| Return on Invested Capital | 156.41% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 24.16 |
| Enterprise Value to EBIT | 0.28 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BiomX Inc
101 employees
CEO: Michael Oster
BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic dis...